A.I. Mobile App Technology
AI Lifestyle & Wellness Applications
At Medical Care Technologies Inc., we are thrilled to unveil our new suite of AI Lifestyle and Wellness Applications. Leveraging our patent-pending AI imaging analysis technology, each app in this category is designed with an artificial intelligence edge that sets it apart from traditional wellness tools. This new category encompasses applications focused on dietary insights, nutritional guidance, fitness tracking, and overall general health. By integrating AI-driven personalization, these apps deliver tailored wellness experiences that appeal to a wide range of users—not just those with specific medical conditions. In essence, we’re expanding from the niche of specialized medical apps into a broader wellness landscape, empowering everyday health improvements for everyone. We believe this expansion will not only drive new revenue potential but also make a meaningful impact on the health and wellness of our global user base.
AI Skin Cancer Screening
Imagine a transformative AI solution that elevates dermatological surveillance by turning routine skin photos into a dynamic, longitudinal body map—intelligently tracking every mole, spot, and lesion across the entire skin surface over time. Unlike traditional tools that analyze individual lesions in isolation, this innovation introduces comprehensive, full-body skin monitoring powered by machine learning, capable of detecting subtle shifts in size, shape, and pigmentation across a patient’s entire dermatological profile. By creating a visual lineage of skin changes, it dramatically improves early detection of melanoma, basal cell carcinoma, and squamous cell carcinoma, while enhancing triage prioritization and long-term screening accuracy. Though clinical dermatology mapping tools exist, a consumer-accessible, AI-integrated lineage tracker remains an open lane for intellectual property and market capture. For tech-savvy investors, this represents a scalable, high-impact opportunity at the nexus of preventive care, computer vision, and personalized health monitoring—where early detection of skin cancers could save lives and reshape global standards in dermatological prevention.
AI Wound-Healing Monitor for Home Care
Picture an AI-powered health solution that transforms everyday smartphone cameras into intelligent wound monitoring tools—capturing sequential images of chronic wounds like diabetic ulcers to track healing trajectories, detect infection risks, and identify stagnation or deterioration in real time. This system leverages automated segmentation, edge detection, and visual pattern recognition to quantify progress with clinical-level precision, all without requiring in-person evaluation. Its true innovation lies in empowering non-clinical users—patients, caregivers, and remote practitioners—with data-driven insights that enable earlier interventions, reduce hospital visits, and improve outcomes. While institutional-grade wound assessment tools exist, the consumer-facing, mobile-first version of this technology remains largely untapped.
mdce technology
About Us - The Details
Medical Care Technologies Inc. (OTC : MDCE) is a rapidly advancing diversified company at the intersection of health wellness and medical AI technology. The company’s proprietary AI imaging platform, now patent-pending (U.S. Provisional Patent Application No. 63/854,935), represents a breakthrough in mobile diagnostics. Built on advanced deep learning, temporal image analysis, and affective computing, this platform transforms an ordinary smartphone into a powerful diagnostic tool, enabling real-time health screenings and disease risk detection without the need for specialized equipment.
At Medical Care Technologies Inc. (OTC PINK: MDCE), we are engineering a portfolio of AI-driven healthcare, dietary and wellness mobile applications that address some of the most pressing diagnostic gaps across multi-billion-dollar markets. Each vertical is powered by a proprietary patent pending deep learning engine, designed to scale globally and deliver measurable impact for patients, providers, and payers.
Together, these verticals form a scalable, AI-powered health ecosystem targeting multiple high-value markets with disruptive potential to redefine digital diagnostics and preventative healthcare worldwide. We plan to launch our first wave of AI integrated mobile applications in 2026, bringing these technologies to the hands of consumers in over 127 countries in 30 different languages.
mdce company roadmap (Updated on 1/9/26)
Short-Term Goals (Coming Weeks / Months)
- Launch the Company’s first completed consumer-based AI mobile application across 127 countries and 30 languages, demonstrating scalability, revenue potential, and global reach.
- Establish MDCE’s first direct, non-subsidiary revenue stream through consumer AI applications.
- Announce the official name and branding of the consumer app, accompanied by a coordinated launch campaign.
- Outline plans for multiple upcoming AI applications across health, wellness, and dietary categories to support near-term revenue generation.
- Continue development and testing of AI-based mobile applications addressing consumer and medical needs, including projects currently in prototype stages to be announced at a later date.
- Subsidiaries Infinite Auctions and Real Game Used to continue generating revenue through high-value collectible sales and AI-based authentication services, respectively.
Near-Term Goals (2026)
- Develop and release one or more medical-grade beta applications.
- Conduct structured beta testing in collaboration with Arizona State University medical student groups.
- Advance select applications into clinical-grade efficacy testing where appropriate.
- Continue expanding the Company’s AI platform capabilities to support both consumer and medical use cases.
Long-Term Goals (2027 and Beyond)
- Pursue an uplisting to OTCQB, subject to meeting qualification standards, to enhance corporate credibility, transparency, and investor access.
- Complete the Company’s provisional patent related to its patent-pending AI image analysis process.
- Explore clinical and institutional partnerships for medical-focused applications.
- Seek clinical validation and/or FDA-style regulatory pathways for one or more medical-grade AI applications, where applicable.
- Evaluate future plans for subsidiaries Infinite Auctions and Real Game Used to operate under their own ticker symbols once MDCE achieves sustained, meaningful revenue growth.
The Company believes that its consumer-focused AI applications can help support operations and growth while it advances through the longer development, testing, and approval timelines required for medical-grade technologies.
CEo - Marshall H. Perkins III
CEO Profile
Marshall Perkins is the CEO of Medical Care Technologies Inc., Infinite Auctions, and Real Game Used, where he leads with vision, resilience, and purpose.
In early 2025, Marshall endured a near-fatal battle with advanced bone cancer that destroyed multiple vertebrae and left him hospitalized for months. At the same time, he faced the devastation of vitiligo. Against all odds, he made a full and miraculous recovery — learning to walk again, beating cancer, and even reversing the skin condition once thought permanent. A walking miracle with a re-ignited purpose in Medical Care Technologies Inc.
Today, Marshall channels this extraordinary second chance into innovation and impact. He works hand-in-hand with a dedicated team of medical experts, medical students, and tech innovators, collaborating daily to push the boundaries of what’s possible in healthcare and technology.
Having nearly lost his life to an unexpected health crisis, Marshall knows firsthand how quickly everything can change. He doesn’t want others to be blindsided the way he was — and that experience has made him more motivated than ever to ensure others have the tools, knowledge, and support to protect their health before it’s too late.